Sithandiwe Mazibuko-Mbeje

Dr. Sithandiwe Mazibuko-Mbeje

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
BNBongani Nkambule
Bongani Nkambule
BJBabalwa Unice Jack
Babalwa Unice Jack
ZMZibusiso Mkandla
Zibusiso Mkandla
TMTinashe Mutize
Tinashe Mutize
SMSithandiwe Mazibuko-Mbeje
Sithandiwe Mazibuko-Mbeje
Metabolic complications in an obese state can be aggravated by an abnormal inflammatory response and enhanced production of reactive oxygen species. Pro-inflammatory response is known to be associated with the formation of toxic reactive oxygen species and subsequent generation of oxidative stress. Indeed, adipocytes from obese individuals display an altered adipokine profile, with upregulated expression and secretion of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin (IL-6). Interestingly, natural compounds, including phenolic enriched foods are increasingly explored for their ameliorative effects against various metabolic diseases. Of interest is gallic acid, a trihydroxybenzoic acid that has progressively demonstrated robust anti-obesity capabilities in various experimental models. In addition to reducing excessive lipid storage in obese subjects, gallic acid has been shown to specifically target the adipose tissue to suppress lipogenesis, improve insulin signaling, and concomitantly combat raised pro-inflammatory response and oxidative stress. This review will revise mechanisms involved in the pathophysiological effects of inflammation and oxidative stress in an obese state. To better inform on its therapeutic potential and improvement of human health, available evidence reporting on the anti-obesity properties of gallic acid and its derivatives will be discussed, with emphases on its modulatory effect on molecular mechanisms involved in insulin signaling, inflammation and oxidative stress.

5 March 2022 in Pharmacological Research
Verified
Journal Article
Closed access
NMNdivhuwo Muvhulawa
Ndivhuwo Muvhulawa
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
Khanyisani ZiqubuKhanyisani Ziqubu
Khanyisani Ziqubu
Sinenhlanhla MthembuSinenhlanhla Mthembu
Sinenhlanhla Mthembu
FMFikile Mthiyane
Fikile Mthiyane
SMSithandiwe Mazibuko-Mbeje
Sithandiwe Mazibuko-Mbeje

20 October 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
SSSamkelisiwe Shabalala
Samkelisiwe Shabalala
Rabia JohnsonRabia Johnson
Rabia Johnson
ABAlbertus Basson
Albertus Basson
Khanyisani ZiqubuKhanyisani Ziqubu
Khanyisani Ziqubu
NHNokulunga Hlengwa
Nokulunga Hlengwa
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
Lipid peroxidation, including its prominent byproducts such as malondialdehyde (MDA) and 4-hydroxy-2-nonenal (4-HNE), has long been linked with worsened metabolic health in patients with type 2 diabetes (T2D). In fact, patients with T2D already display increased levels of lipids in circulation, including low-density lipoprotein-cholesterol and triglycerides, which are easily attacked by reactive oxygen molecules to give rise to lipid peroxidation. This process severely depletes intracellular antioxidants to cause excess generation of oxidative stress. This consequence mainly drives poor glycemic control and metabolic complications that are implicated in the development of cardiovascular disease. The current review explores the pathological relevance of elevated lipid peroxidation products in T2D, especially highlighting their potential role as biomarkers and therapeutic targets in disease severity. In addition, we briefly explain the implication of some prominent antioxidant enzymes/factors involved in the blockade of lipid peroxidation, including termination reactions that involve the effect of antioxidants, such as catalase, coenzyme Q10, glutathione peroxidase, and superoxide dismutase, as well as vitamins C and E.

16 February 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
Khanyisani ZiqubuKhanyisani Ziqubu
Khanyisani Ziqubu
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
Sinenhlanhla MthembuSinenhlanhla Mthembu
Sinenhlanhla Mthembu
BNBongani B. Nkambule
Bongani B. Nkambule
SMSihle E. Mabhida
Sihle E. Mabhida
SMSithandiwe Mazibuko-Mbeje
Sithandiwe Mazibuko-Mbeje
Brown adipose tissue (BAT), a thermoregulatory organ known to promote energy expenditure, has been extensively studied as a potential avenue to combat obesity. Although BAT is the opposite of white adipose tissue (WAT) which is responsible for energy storage, BAT shares thermogenic capacity with beige adipose tissue that emerges from WAT depots. This is unsurprising as both BAT and beige adipose tissue display a huge difference from WAT in terms of their secretory profile and physiological role. In obesity, the content of BAT and beige adipose tissue declines as these tissues acquire the WAT characteristics via the process called “whitening”. This process has been rarely explored for its implication in obesity, whether it contributes to or exacerbates obesity. Emerging research has demonstrated that BAT/beige adipose tissue whitening is a sophisticated metabolic complication of obesity that is linked to multiple factors. The current review provides clarification on the influence of various factors such as diet, age, genetics, thermoneutrality, and chemical exposure on BAT/beige adipose tissue whitening. Moreover, the defects and mechanisms that underpin the whitening are described. Notably, the BAT/beige adipose tissue whitening can be marked by the accumulation of large unilocular lipid droplets, mitochondrial degeneration, and collapsed thermogenic capacity, by the virtue of mitochondrial dysfunction, devascularization, autophagy, and inflammation.

1 August 2020 in Pharmacological Research
Verified
Journal Article
Closed access
Khanyisani ZiqubuKhanyisani Ziqubu
Khanyisani Ziqubu
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
EJElizabeth Joubert
Elizabeth Joubert
CMChristo J.F. Muller
Christo J.F. Muller
JLJohan Louw
Johan Louw
SMSithandiwe Mazibuko-Mbeje
Sithandiwe Mazibuko-Mbeje

1 February 2020 in Cytokine
Verified
Journal Article
Closed access
TMThabsile Mahlangu
Thabsile Mahlangu
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
TNTawanda Nyambuya
Tawanda Nyambuya
VMVuyolwethu Mxinwa
Vuyolwethu Mxinwa
SMSithandiwe Mazibuko-Mbeje
Sithandiwe Mazibuko-Mbeje
BNBongani Nkambule
Bongani Nkambule